Showing results (31-40 of 203) with videos related to
Sort By:
Pageof 21
International Journal of Hematology|October 8, 2008
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphomaKatja C Weisel, Eckhart Weidmann, Ioannis Anagnostopoulos, et al.Annals of the New York Academy of Sciences|March 16, 2007
Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacitiesXingkui Xue, Zhen Cai, Gabriele Seitz, et al.Annals of Hematology|July 1, 2014
Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatmentManola Zago, Katharina Oehrlein, Corinna Rendl, et al.Annals of the New York Academy of Sciences|March 31, 2007
Novel markers for the prospective isolation of human MSCHans-Jörg Bühring, Venkata Lokesh Battula, Sabrina Treml, et al.International Journal of Hematology|December 23, 2008
Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomideKatja C Weisel, Michael Böckeler, Leonardo Bianchi, et al.Annals of the New York Academy of Sciences|October 3, 2009
Phenotypic characterization of distinct human bone marrow-derived MSC subsetsHans-Jörg Bühring, Sabrina Treml, Flavianna Cerabona, et al.Haematologica|February 27, 2003
Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cellsWichard Vogel, Frank Grünebach, Conrad A Messam, et al.Journal of Cancer Research and Clinical Oncology|August 15, 2015
Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantationSebastian P Haen, Michael Schumm, Christoph Faul, et al.Haematologica|December 30, 2006
Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphomaJörg T Hartmann, Ines Meisinger, Stefan M Kröber, et al.Transfusion|September 25, 2014
Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusionChristof Weinstock, Robert Möhle, Christiane Dorn, et al.Pageof 21